The small molecule company with end-to-end capabilities
Please log in for more information
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle.
With over 35 years’ experience and a growing team of over 2,000 experts servicing global clients from sites in North America and Europe, the company is tried and trusted in branded and generic markets for API and dosage form development and manufacturing.
Cambrex provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics.
Cambrex offers a range of specialist drug substance technologies including biocatalysis, continuous flow, controlled substances, solid state science and highly potent APIs. In addition, Cambrex can support conventional dosage forms including solids, semi-solids and liquids and also has the capability to manufacture specialist dosage forms; solid dose, fixed dose, pediatric, bi-layer, stick packs, topicals, controlled substances, sterile and non-sterile dose forms.
